Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human OLFML2B ELISA Kit (AC3877)
Cat.#: ASET-2466
Specifications
Description Human OLFML2B ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human OLFML2B concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 13.93 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 300-4800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1938 Mouse Neurotrophin 3 ELISA Kit (AC3349) Quantitative inquiry ASET-2530 Rat Antidiuretic Hormone ELISA Kit (AC3941) Quantitative inquiry ASET-1203 Human EYA2 ELISA Kit (AC2614) Quantitative inquiry ASET-1886 Human GDF7 ELISA Kit (AC3297) Quantitative inquiry ASET-2106 Human Aromatase ELISA Kit (AC3517) Quantitative inquiry ASET-2429 Human PPAR gamma ELISA Kit (AC3840) Quantitative inquiry ASET-1128 Rat Iba1 ELISA Kit (AC2539) Quantitative inquiry ASET-1232 Human NENF ELISA Kit (AC2643) Quantitative inquiry ASET-1788 Human MAN2B1 ELISA Kit (AC3199) Quantitative inquiry ASET-1123 Rat Calbindin ELISA Kit (AC2534) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket